Scarcity: Mangaluru urged not to waste water; supply only once in two days

Bengaluru, Apr 12: As many as 17 new cases of coronavirus were confirmed on Sunday in Karnataka, taking the total number of infected to 232, the health department said.

This includes six deaths and 54 discharges.

According to the bulletin issued by the health department, six cases were reported from Vijayapura, four cases in Belagavi, three each in Bengaluru city and Kalaburagi and one in Mysuru.

Among the 17, four people are suffering from Severe Acute Respiratory Illness (SARI) -- two of whom are in Bengaluru and one each in Vijayapura and Kalaburagi, the department said.

Following the sudden spurt in cases in Vijayapura, the department has initiated contact tracing.

Ever since the outbreak of COVID-19, Bengaluru continued to top the list with 76 cases, followed by Mysuru with 48 cases, Belagavi with 14 cases, Kalaburagi with 13 cases and Dakshina Kannada with 12 cases.

Bengaluru, Mar 15: Amid growing coronavirus cases, the Karnataka government on Sunday postponed examinations of class 7, 8 and 9 till March 31, 2020.

The revised dates for examinations will be announced after reviewing the situation. The directive was issued by state education minister S Suresh Kumar on Sunday morning.

On Friday, the government had shut all educational institutions, malls, and clubs for a week.

Chief Minister BS Yediyurappa had said no one should travel unless it is an emergency.

"All malls, cinema halls, pubs, wedding ceremonies and other large gatherings in the Karnataka have been banned for another one week," Chief Minister Yediyurappa had said.

Notably, the number of coronavirus cases in the country has risen to 93, informed the Union Ministry of Health and Family Welfare today.

So far, two deaths due to the COVID-19 have been reported in the country. In the wake of spurt in cases of coronavirus across the country, the Central Government on Saturday decided to treat the deadly virus as a "notified disaster".

Coronavirus, which originated in China's Wuhan city in December last year, has so far spread to more than 100 countries, infecting over 1,30,000 people. The World Health Organisation (WHO) has declared coronavirus a pandemic.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.